Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320151 · ClinicalTrials.gov registry record
Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 3,087
- Enrollment target
NCT00320151: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00320151 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 3,087 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320151 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 3,087 participants
- Enrollment target
Study Summary
This protocol is designed to gather a small amount of blood from patients seen in the New York Presbyterian Hospital-Weill Cornell Medical Center Pulmonary, Critical Care unit, and 5 West floor (Pulmonary Floor) for clinical care associated with chronic lung disease. This protocol will also survey medical records of patients with chronic lung disease, in order to study the clinical characteristics of these individuals. Investigators aim to understand the genetics of chronic lung diseases, and will use the serum and DNA from this blood to perform various genotyping studies such as such as genomic/gene expression studies of individuals with chronic lung diseases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,087 participants |
| Start Date | 2006-04 |
| Est. Completion | 2015-08 |
What the finished NCT00320151 record still lists
NCT00320151 is an observational study that tracks outcomes without assigning an intervention. Its 3,087 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00320151 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00320151 about?
NCT00320151 is a clinical study titled "Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases". This protocol is designed to gather a small amount of blood from patients seen in the New York Presbyterian Hospital-Weill Cornell Medical Center Pulmonary, Critical Care unit, and 5 West floor (Pulmonary Floor) for clinical care associated with chronic lung disease. This protocol will also survey m...
What is the current status of trial NCT00320151?
This trial is currently completed. The enrollment target is 3,087 participants. The study started on 2006-04. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT00320151?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia